Therapeutic potential of CD20 x CD3 bispecific antibodies

FHS
April 5, 2024
5:24 am

On Monday, March 25th, 2024, the U.S. FDA declined approval for Regeneron’s Odronextamab for two forms of lymphoma due to concerns over the progress of ongoing confirmatory trials.

Incarcerated women face challenges in accessing menstrual hygiene products

A new study has shown that among incarcerated women, many have to trade or barter to access menstrual hygiene products.

August 9, 2023

Proposed breast cancer screening recommendations don’t go far enough

Editor’s note: Henry Izawa is President and CEO of FUJIFILM Healthcare Americas Corporation, which manufactures digital imaging devices, including those used in mammography. Many women put

June 21, 2023

Black women founders offer health tech solutions to combat Black maternal mortality

When Black people receive maternal care, they are often not treated the same as white people. In 2016, when Simmone Taitt had her first pregnancy

May 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.